Novelion Therapeutics Inc.

CIK 827809 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Novelion Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Mar 10, 2023REVOKED9999999997-23-000889
Jul 14, 20208-K0001104659-20-083297
Jun 12, 20208-K0001104659-20-072998
Mar 30, 2020NT 10-K0001104659-20-040397
Feb 13, 2020SC 13G/A0000935836-20-000116
Jan 21, 2020SC 13G/A0001104659-20-005443
Jan 21, 20208-K0001104659-20-005619
Jan 15, 2020SC 13G/A0000919574-20-000372
Jan 15, 202030000919574-20-000374
Jan 10, 20208-K0001104659-20-002768
Jan 10, 2020SC 13G/A0001193125-20-005508
Jan 3, 20208-K0001104659-20-000921
Dec 17, 201925-NSE0001354457-19-000660
Dec 12, 201940001567619-19-022982
Dec 11, 20198-K0001104659-19-071663
Dec 9, 201940001567619-19-022780
Nov 26, 201940001567619-19-022304
Nov 22, 20198-K0001104659-19-066325
Nov 15, 2019NT 10-Q0001104659-19-064758
Nov 5, 20198-K0001104659-19-059984
Oct 16, 201940001567619-19-019667
Oct 8, 20198-K0001104659-19-053302
Oct 8, 2019DEFA14A0001104659-19-053303
Oct 4, 2019DEFA14A0001104659-19-053025
Oct 3, 2019DEFA14A0001104659-19-052994